Printer Friendly
Dictionary, Encyclopedia and Thesaurus - The Free Dictionary
3,903,365,265 visitors served.
forum Join the Word of the Day Mailing List For webmasters
?
Dictionary/
thesaurus
Medical
dictionary
Legal
dictionary
Financial
dictionary
Acronyms
 
Idioms
Encyclopedia
Wikipedia
encyclopedia
?

tirofiban

   Also found in: Wikipedia 0.02 sec.
tirofiban /ti·ro·fi·ban/ (ti″ro-fi´ban) a platelet inhibitor, used as the hydrochloride salt in prophylaxis of thrombosis in unstable angina or in myocardial infarction that is not characterized by abnormal Q waves.
tirofiban,
an antiplatelet agent.
indication It is used to treat acute coronary syndrome.
contraindications The following factors prohibit its use: known hypersensitivity to this drug, active internal bleeding, stroke, major surgery, severe trauma, intracranial neoplasm, aneurysm, and hemorrhage.
adverse effects Bleeding is a life-threatening effect of tirofiban. Other adverse reactions include bradycardia, dizziness, dissection, coronary artery edema, pain in the legs and/or pelvis, and sweating. Rash is a common side effect.

tirofiban [ti″ro-fi´ban]
a platelet inhibitor, used as the hydrochloride salt in prophylaxis of thrombosis in unstable angina or in myocardial infarction that is not characterized by abnormal Q waves; administered intravenously.

tirofiban
Aggrastat®, MK-383 Cardiology A potent short-acting, nonpeptide inhibitor of platelet glycoprotein IIb/IIIa or integrin αIIbβ3 receptor which, when administered with heparin, ↓ ischemic events in Pts with acute coronary syndrome. See PRISM, PRISM-PLUS.


Want to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit the webmaster's page for free fun content.
?Page tools
Printer friendly
Cite / link
Feedback
Add definition
Mentioned in?  References in periodicals archive?   Medical browser?   Full browser?
 
A standard treatment for patients with troponin-positive acute coronary syndrome is tirofiban which is a "short-acting non-peptide inhibitor of the GPIIb/IIIA receptor.
Among patients with high risk NSTE ACS (ie, with ST depression on ECG and/or elevated markers of cardiac necrosis), precath lab therapy with either eptifibatide or tirofiban plus unfractionated heparin was associated with a 10 to 20% decrease in death/MI.
In contrast, data on all patients in the lamifiban trial show just a modest, statistically insignificant improvement, similar to that seen in tests of eptifibatide and tirofiban, two other intravenous-use GP IIb/IIIa receptor inhibitors already on the market.
 
 
 
Medical Dictionary
?

Terms of Use | Privacy policy | Feedback | Advertise with Us | Copyright © 2012 Farlex, Inc.
Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.